News Spotlight: Organogenesis Holdings Inc. (Nasdaq: ORGO)

Organogenesis Holdings Inc. (Nasdaq: ORGO) stock observed trading -97.41% off 52-week high price. On the other end, the stock has been noted 28.18% away from low price over the last 52-weeks. The stock disclosed a move of 11.53% away from 50 day moving average and -32.28% away from 200 day moving average. Moving closer, we can see that shares have been trading 7.59% off 20-day moving average. It has market cap of $718.7M .

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, declared its 2019 sponsorship of the American Podiatric Medical Association (APMA), including support for two of the APMA’s leading educational programs: The Residency Education Resource Center (REdRC) and the Young Physicians’ Institute (YPI).

Organogenesis will also exhibit at the APMA 2019 Annual Scientific Meeting, The National, taking place July 11-14  in Salt Lake City, UT. Products from the Organogenesis advanced wound care portfolio will be highlighted with product demonstrations and information at the Organogenesis booth #401.

Additionally, Organogenesis will sponsor a lunch symposium, “Get Wounds Moving with a Comprehensive Portfolio of Skin Substitutes,” on Thursday, July 11 from 12-1 p.m. in Ballroom G/I. The symposium will feature guest speaker Ira Kraus, DPM, FASPS, FACFAS, APMA Representative to the AMA CPT Panel, APMA Coding Committee Member, and Past President of APMA.

Gary S. Gillheeney, Sr., President and CEO of Organogenesis said “We are proud to have sponsored the APMA for many years, and to continue supporting its goals of promoting foot and ankle health through a wide array of educational events and programs,”.

The American Podiatric Medical Association is the premier national organization representing the vast majority of podiatrists in the United States. Founded in 1912, the APMA is the leading resource for foot and ankle health information.

The APMA REdRC was developed to offer an educational lecture program free of charge to residents and residency directors through its online portal. For the past seven years, Organogenesis has supported the development of this important tool as a founding sponsor.

Now in its ninth year, the YPI program provides future leaders in podiatric medicine with a valuable and timeless educational resource. This year’s program will present young practitioners with an overview of the state of podiatry, including varied practice settings as well as legislative and regulatory initiatives that affect the field.

 The USA based company Organogenesis Holdings Inc. moved with change of 0.75% to $8.05 with the total traded volume of 20728 shares in recent session versus to an average volume of 60.7K. The stock was observed in the 5 days activity at 0.63%. The one month performance of stock was 13.86%. ORGO’s shares are at 1.64% for the quarter and driving a -18.69% return over the course of the past year and is now at -20.69% since this point in 2018.  The average volatility for the week and month was at 5.52% and 4.86% respectively. There are 89.28M shares outstanding and 6.81M shares are floated in market.

Leave a Reply

Your email address will not be published. Required fields are marked *